Colgate Palmolive : 1Q 2026 Earnings Presentation (e112a5)
CL
Published on 05/01/2026 at 07:05 am EDT
1Q 2026 EARNINGS PRESENTATION
May 1, 2026
May 2026
Notice for Investor Presentation
Please review the following first quarter 2026 earnings presentation in conjunction with our first quarter 2026 earnings press release, our first quarter 2026 prepared management remarks and additional information regarding our non-GAAP financial measures, including GAAP to non-GAAP reconciliations, which are available in the Investor Center section of our website at https://www.colgatepalmolive.com/investors and in the first quarter 2026 earnings press release. Our presentation contains non-GAAP financial measures, which differ from our reported results prepared in accordance with U.S. generally accepted accounting principles (GAAP). These non-GAAP financial measures of operating results exclude items that, either by their nature or amount, management would not expect to occur as part of the Company's normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, acquisition-related costs, gains and losses from certain divestitures and certain other unusual,
non-recurring items. We may also refer to organic sales growth, which is Net sales growth excluding the impact of foreign exchange, acquisitions and divestments, or to free cash flow before dividends, which we define as Net cash provided by operations less Capital expenditures. A complete, quantitative reconciliation between our reported results and these non-GAAP financial measures is available in the Investor Center section of our website at https://www.colgatepalmolive.com/investors and in Tables 3, 5 and 6 of the first quarter 2026 earnings press release.
Our presentation may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (the SEC) in its rules, regulations and releases) that set forth anticipated results based on management's current plans and assumptions. These statements are made, except as otherwise noted with respect to tariffs, on the basis of our views and assumptions as of May 1, 2026, and we undertake no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, we do not, nor does any other person, assume responsibility for the accuracy and completeness of these statements. We caution investors that forward-looking statements are not guarantees of future performance and actual events or results may differ materially from those statements. For information about factors that could impact the Company's business and cause actual results to differ materially from forward-looking statements, refer to the Company's filings with the SEC (including, but not limited to, the information set forth under the captions "Risk Factors" and "Cautionary Statement on Forward-Looking Statements" in the Company's Annual Report on Form 10-K for the year ended December 31, 2025 and subsequent filings with the SEC). Copies of these filings may be obtained upon request from the Company's Investor Relations Department or on the Company's website at https://www.colgatepalmolive.com/investors.
We are a $20.4B global consumer products company with a diverse and dedicated team serving over 200 countries and territories.
As a caring, innovative growth company, we are united behind our purpose: reimagining a healthier future for all people, their pets and our planet.
Oral Care
Pet Nutrition
Personal Care
Home Care
1Q 2026 Highlights
Growth accelerated versus 4Q25 in Net sales, Organic sales, volume and Base Business operating profit, net income and EPS, despite a very challenging operating environment
Net sales increased 8.4%; Organic sales* increased 2.9%, including a 0.6% negative impact from lower private label pet food sales having exited that non-strategic business
Net sales and Organic sales grew in every category during the quarter and in four of five divisions
Base Business EPS* increased 7%
Free cash flow* increased 28% year to date
Global toothpaste market share was up 30 basis points on a volume basis and up 10 basis points on a value basis year to date
*Non-GAAP
"These results underscore the resilience of our business model as we are able to execute against our long-term strategy while delivering strong results in a difficult operating environment. While we expect the volatile macroeconomic conditions and slower category growth to continue in 2026, we are aligned behind our 2030 strategy to deliver consistent, compounded earnings per share growth and drive long-term shareholder value."
Noel Wallace Chairman, President and Chief Executive Officer
Accelerating Change for 2030 to Unlock More Growth
Leverage the global reach and penetration of our brands
Build the incremental benefit of superior, science-based innovation
Harness the power of best in class
omni-channel demand generation
Lead in capabilities like data, analytics and AI
Evolve our high-impact, inclusive culture
Strategic Growth and Productivity Program
Supporting Our 2030 Strategy
Key Initiatives
Includes initiatives to optimize the Company's global supply chain and to better align the Company's organizational structure to support its strategic initiatives, including accelerating innovation, data, analytics, AI and omni-channel demand generation
Financial Projections
Projected to result in cumulative pre-tax charges totaling between
$350 and $550 million over the course of the three-year program.* Cumulative pre-tax savings are projected to be $200 million to
$300 million, annually.*
*Once all initiatives are approved and implemented. The Company expects substantially all of the charges to be incurred by December 31, 2028.
Organic Sales Growth
1Q 2026: Org sales growth +2.9%, Org volume growth +0.6%, Pricing growth +2.2%
2026
Guidance*
}
Long-Term Target Range 3-5%
Non-GAAP
*2026 Guidance: 1% to 4%
2026 Guidance - GAAP
Based on current spot rates and including the estimated impact of tariffs announced and finalized as of April 29, 2026:
Net sales growth still expected to be 2% to 6%, including a low-single-digit positive impact from foreign exchange
Gross profit margin now expected to be down for the year (versus up previously)
Advertising still expected to be up as a percentage of net sales and on a dollar basis
GAAP EPS still expected to be up double digits
2026 Guidance - Non-GAAP/Base Business
Based on current spot rates and including the estimated impact of tariffs announced and finalized as of April 29, 2026:
Organic sales growth still expected to be 1% to 4%. This includes the impact from our exit from the private label pet food business.
Gross profit margin now expected to be down for the year (versus up previously)
Advertising still expected to be up as a percentage of net sales and on a dollar basis
Base Business EPS still expected to be up low to mid-single digits
Delivered Record Free Cash Flow in 2025
1Q 2026 YTD: $0.6 billion +28% YOY
$ in billions
Non-GAAP
Investing for growth and productivity through capital expenditures
Returning value to shareholders through dividends and share repurchases
$0.7 billion returned to shareholders in 2026 year to date
M&A aligned with our strategy
Consistent Dividend Growth
Of Dividend Increases
Of Dividend Payments
Cash Returned to Shareholders Last 10 Years
Dividends Paid Per Share
As of December 31, 2025
Science-led, Core and Premium Innovation
elmex Sensitivity + Gum
Innovation strengthening our presence in the sensitivity segment
elmex is the
Source: Based on BRMO dentist study conducted in the relevant market
elmex Long-Term Growth in Europe
Fueled By Science-Driven Innovation
Toothpaste SoM $
Source: Worldview through March 2026
5% fluoride varnish for the treatment of dental sensitivity
Applied in chair by the dental professional
Sensitivity relief for a comfortable dental visit during teeth whitening or cleaning procedures
New meridol Fast Action in Europe
Fast soothing feeling on irritated and sensitive gums*
* 2 weeks consumer study, 155 subjects, Germany 2025, showed fast results within a few days
Source: Nielsen value share YTD Nov 2025, Germany
Disclaimer
Colgate-Palmolive Company published this content on May 01, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 01, 2026 at 11:04 UTC.